Published in J Infect Dis on December 01, 1994
A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004. Epidemiol Infect (2006) 1.43
Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Microbiol (1997) 1.20
Molecular evolution of Puumala hantavirus. J Virol (2001) 1.13
Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol (2007) 1.13
Hantavirus outbreak, Germany, 2007. Emerg Infect Dis (2008) 1.07
Risk factors for human infection with Puumala virus, southwestern Germany. Emerg Infect Dis (2009) 1.07
Nephropathia epidemica in metropolitan area, Germany. Emerg Infect Dis (2007) 1.02
Network "Rodent-borne pathogens" in Germany: longitudinal studies on the geographical distribution and prevalence of hantavirus infections. Parasitol Res (2008) 0.98
In Search for Factors that Drive Hantavirus Epidemics. Front Physiol (2012) 0.96
Expression of the nucleoprotein of the Puumala virus from the recombinant Semliki Forest virus replicon: characterization and use as a potential diagnostic tool. Clin Diagn Lab Immunol (2003) 0.94
First molecular evidence for Puumala hantavirus in Poland. Viruses (2014) 0.91
Spatiotemporal dynamics of Puumala hantavirus associated with its rodent host, Myodes glareolus. Evol Appl (2015) 0.84
Hemorrhagic fever with renal syndrome: diagnostic problems with a known disease. J Clin Microbiol (2001) 0.77
Life with 6000 genes. Science (1996) 41.51
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 8.32
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62
Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55
Complete DNA sequence of yeast chromosome XI. Nature (1994) 3.51
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34
Immunization for Ebola virus infection. Nat Med (1998) 3.27
Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24
Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol (1985) 3.06
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95
The YTA10-12 complex, an AAA protease with chaperone-like activity in the inner membrane of mitochondria. Cell (1996) 2.80
Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69
Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Bornavirus Study Group. Lancet (1997) 2.54
Rpn4p acts as a transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and other genes in yeast. FEBS Lett (1999) 2.54
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44
Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis (2007) 2.37
Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Functional analysis of 150 deletion mutants in Saccharomyces cerevisiae by a systematic approach. Mol Gen Genet (1999) 2.26
Mapping of yeast tRNAs by two-dimensional electrophoresis on polyacrylamide gels. FEBS Lett (1975) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22
An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis (1997) 2.19
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17